Mode
Text Size
Log in / Sign up

Brain Metastasis

Subtypes of Brain Metastasis

Brain Metastases 9 Brain tumor 8 Pituitary adenoma 2

22 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Brain Metastasis

3 trials tracked for Brain Metastasis.

3Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3
  1. Phase 2 Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis Completed
  2. Phase 2 Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases Completed
  3. Phase 2 Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC) Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Brain Metastasis

Can a high neutrophil-to-lymphocyte ratio predict if a lung cancer patient will develop brain metastasis?

Yes, a high neutrophil-to-lymphocyte ratio (NLR) is linked to a higher risk of developing brain metastasis in lung cancer patients, according to a meta-analysis and other studies.

Full answer →
How well does osimertinib work for lung cancer patients who have active brain metastasis?

Osimertinib is effective for EGFR-mutated NSCLC patients with active brain metastases, with real-world data showing median progression-free survival of 12.4 months and intracranial responses, though resistance can develop.

Full answer →
Is stereotactic radiotherapy an effective treatment option for patients with brain metastasis?

Yes, stereotactic radiotherapy is an effective treatment for brain metastases, offering high local control rates and preserving cognitive function.

Full answer →
What are the microenvironment mechanisms that drive lung cancer brain metastasis?

Lung cancer brain metastasis is driven by tumor cells co-opting brain developmental pathways, secreting exosomal CEMIP and LCN2, and recruiting astrocytes and macrophages to create a supportive niche.

Full answer →
What are the risks of brain metastasis in patients diagnosed with lung cancer?

Brain metastases are common in lung cancer, especially small cell (15% at diagnosis) and non-small cell types, with elevated neutrophil-to-lymphocyte ratio as a risk factor; targeted therapies like osimertinib show high intracranial response rates.

Full answer →
See all 5 questions about Brain Metastasis →

All Brain Metastasis Articles